USNA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
USNA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-06), Usana Health Sciences's share price is $25.48. Usana Health Sciences's Book Value per Share for the quarter that ended in Dec. 2024 was $27.91. Hence, Usana Health Sciences's PB Ratio of today is 0.91.
Good Sign:
Usana Health Sciences Inc stock PB Ratio (=0.91) is close to 10-year low of 0.91.
The historical rank and industry rank for Usana Health Sciences's PB Ratio or its related term are showing as below:
During the past 13 years, Usana Health Sciences's highest PB Ratio was 7.48. The lowest was 0.91. And the median was 4.56.
During the past 12 months, Usana Health Sciences's average Book Value Per Share Growth Rate was 7.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 10.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Usana Health Sciences was 77.70% per year. The lowest was -13.30% per year. And the median was 13.90% per year.
The historical data trend for Usana Health Sciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
3.67 | 4.97 | 2.35 | 2.06 | 1.29 |
Usana Health Sciences Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
2.06 | 1.85 | 1.68 | 1.36 | 1.29 |
For the Packaged Foods subindustry, Usana Health Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Usana Health Sciences's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Dec. 2024) |
= | 25.48 | / | 27.912 | |
= | 0.91 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Usana Health Sciences (NYSE:USNA) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Usana Health Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Brent Neidig | officer: CO & Man. Dir. of China | 3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120 |
Joshua Foukas | officer: Chief Legal Officer | 3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120 |
John Turman Fleming | director | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
David Mulham Mulham | officer: Chief Field Development Office | 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Gilbert A Fuller | officer: CFO and Executive V.P. | 55 WANDERWOOD WAY, SANDY UT 84092 |
Jim Brown | officer: Chief Production Officer | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Peggie Pelosi | director | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84111 |
Paul A. Jones | officer: CFO | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Myron W Wentz | director | 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120 |
G Doug Iiekking | officer: VP of Finance | C/O USANA HEALTH SCIENCES INC, 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Daniel A. Macuga | officer: Chief Communications Officer | 3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120 |
Kevin Guest | officer: E.V.P. of Marketing | 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Walter Noot | officer: Chief Information Officer | 3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120 |
Robert A Sinnott | officer: Chief Scientific Officer | 400 55 WATER STREET, VANCOUVER A1 V6B1A1 |
Frederic J Winssinger | director | 2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018 |
From GuruFocus
By GuruFocus News • 10-24-2024
By GuruFocus News • 10-23-2024
By GuruFocus News • 02-27-2025
By GuruFocus News • 03-04-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 11-05-2024
By PRNewswire • 03-03-2025
By PRNewswire • 01-02-2025
By Business Wire • 10-22-2024
By Business Wire • 01-06-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.